Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Glycosylated hemoglobin and the risk of breast cancer in type 2 diabetes: a meta analysis and case control study
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: A, Vijayakumar (KMCH, Pharmacy Services, Coimbatore, India)
- Co-author(s): Vijayakumar A: Pharmacy Services, KMCH, Coimbatore, India
Geethu Grace Prakash: Pharmacy Practice, KMCH COP, Coimbatore, India
Velayutham P: Endocrinology, KMCH, Coimbatore, India
BackgroundsDiabetes mellitus is a commonly prevailing disease and cancer in association with it is an unravelling major health concern. Research studies conducted globally have suggested that HbA1c may or may not be associated with risk of breast cancer in type 2 diabetic patients.
To evaluate whether HbA1c level is associated with breast.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019